Categories Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy Durvalumab (Dosage Modifications-7) In this article we will discuss Durvalumab (Dosage Modifications-7) Post author By priyeshbanerjeept Post date 5 May 2023 No Comments on Durvalumab (Dosage Modifications-7) In this article, we will discuss Durvalumab (Dosage Modifications-7). So, let’s get started. Neurological Toxicities Grade 2 – Withhold Grade 3 or 4 – Permanently discontinue Share this:TweetMoreWhatsAppLike Loading... Related Tags Anticancer Drugs, Durvalumab, Medicine, Oncology, Pharmacology, Physiotherapy ← Durvalumab (Preparation and Administration) → Durvalumab (Dosage Modifications-8) Leave a ReplyCancel reply This site uses Akismet to reduce spam. Learn how your comment data is processed.